Abstract
Areas covered: An in-depth analysis of the COVID-19 positive cases in the UK throughout the year, hospitalizations, patients in critical care, and COVID-19 associated deaths.
Expert opinion: The COVID-19 associated hospital admission accounts to 15% of total COVID-19 positive cases in November 2020. The percentage of total COVID-19 positive patients in the country died from the disease was under 4% in November 2020. Total deaths in England (all-cause) from June to October 2020 were similar to the historic averages. Age was the single most determinator of COVID-19 associated mortality, 50 years or older accounted for 98% of total COVID deaths. Age distribution of COVID-19 associated deaths in 2020 was similar to all-cause mortality age distribution in 2019. There was no significant improvement in the survival rate of COVID-19 patients receiving critical care. This prompts an urgent need to invest in novel antiviral therapeutics to save the most vulnerable in the society.
| Original language | English |
|---|---|
| Pages (from-to) | 973-978 |
| Number of pages | 6 |
| Journal | Expert Review of Respiratory Medicine |
| Volume | 15 |
| Issue number | 8 |
| Early online date | 11 Feb 2021 |
| DOIs | |
| Publication status | Published - 1 Aug 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK'. Together they form a unique fingerprint.-
Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115–1126
Merchant, H., 11 Apr 2022, In: Current Issues in Molecular Biology. 44, 4, p. 1661-1663 3 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access11 Link opens in a new tab Citations (Scopus) -
Inadvertent injection of COVID-19 vaccine into deltoid muscle vasculature may result in vaccine distribution to distance tissues and consequent adverse reactions
Merchant, H., 1 Jul 2022, In: Postgraduate Medical Journal. 98, 1161, p. e5 1 p., 141119.Research output: Contribution to journal › Letter › peer-review
Open Access12 Link opens in a new tab Citations (Scopus) -
Why COVID vaccines for young children (5–11 years) are not essential at this moment in time?
Merchant, H., 28 Mar 2022, In: Journal of Pharmaceutical Policy and Practice. 15, 1, 4 p., 25.Research output: Contribution to journal › Comment/debate › peer-review
Open Access3 Link opens in a new tab Citations (Scopus) -
Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials
Ali, A. S., Hasan, S. S., Kow, C. S. & Merchant, H., 1 Oct 2021, In: Clinical Nutrition ESPEN. 45, p. 26-32 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile40 Link opens in a new tab Citations (Scopus) -
Myocarditis followed by CoViD-19 vaccines: A cause for concern or a reversible minor effect?
Merchant, H., 14 Jun 2021, In: The BMJ. 1 p., bmj.n1244/rr-10.Research output: Contribution to journal › Letter › peer-review
Open Access
Press/Media
-
Covid-19: Whatever happened to the Novavax vaccine?
Merchant, H.
8/12/21
1 Media contribution
Press/Media: Expert Comment
-
Lactoferrin supplements could aid recovery of COVID19 and other Respiratory Infections
Merchant, H. & Hasan, S. S.
19/10/21 → 22/11/21
24 items of Media coverage, 1 Media contribution
Press/Media: Research
-
Can the response to Covid-19 help address other global challenges?
Merchant, H.
5/11/21
1 item of Media coverage
Press/Media: Expert Comment
-
Meet the scientist behind the latest research on Lactoferrin that's got the papers talking
Merchant, H.
3/11/21
1 Media contribution
Press/Media: Research
-
COVID-19 vaccines in children and adolescents: Strategies to improve vaccine safety and efficacy
Merchant, H.
28/10/21
1 Media contribution
Press/Media: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver